Novel thermosensitive polymeric micelles for docetaxel delivery

Journal of Biomedical Materials Research - Part A

Volumn 81, Issue 4, 2007, Pages 847-857

  Yang, Mi ^a   Ding, Yitao ^a   Zhang, Leyang ^b   Qian, Xiaoping ^a   Jiang, Xiqun ^b   Liu, Baorui ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Antitumor; Docetaxel; Micelles; Targeted drug delivery; Thermosensitive material

Indexed keywords

COPOLYMERS; DRUG DELIVERY; DYNAMIC LIGHT SCATTERING; HYPERTHERMIA THERAPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYMER MATRIX; X RAY DIFFRACTION;

ANTITUMOR DRUGS; DOCETAXEL; LOW CRITICAL SOLUTION TEMPERATURE (LCST); TARGETED DRUG DELIVERY; THERMOSENSITIVE MATERIALS;

MICELLES;

COPOLYMER; DOCETAXEL; POLY(N ISOPROPYLACRYLAMIDE CO ACRYLAMIDE) B POLY(LACTIDE); UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DIALYSIS; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; HUMAN; HUMAN CELL; HYPERTHERMIA; IN VITRO STUDY; LIGHT SCATTERING; MICELLIZATION; NUCLEAR MAGNETIC RESONANCE; POLYMERIZATION; PRECIPITATION; STRUCTURE ANALYSIS; THERMOREGULATION; X RAY DIFFRACTION;

EID: 34249689592     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31129     Document Type: Article

References (32)

1. Andresen TL, Jensen SS, Jorgensen K. Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release. Prog Lipid Res 2005;44:68-97.
2. Valero V, Holmes FA, Walters RS, Theriault RL, Esparza L, Fraschini G, Fonseca GA, Bellet RE, Buzdar AU, Hortobagyi GN. Phase II trial of docetaxel: A new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer. J Clin Oncol 1995;13: 2886-2894.
3. Ferraresi V, Milella M, Vaccaro A, D'Ottavio AM, Papaldo P, Nistico C, Marsella A, Carpino A, Giannarelli D, Terzoli E, Cognetti F. Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: A phase II study. Am J Clin Oncol Cancer Clin Trials 2000;23:132-139.
4. Esmaeli B, Valero V, Ahmadi MA, Booser D. Canalicular stenosis secondary to docetaxel (Taxotere) - A newly recognized side effect. Ophthalmology 2001;108:994-995.
5. Schrump DS, Nguyen DM. Novel molecular targeted therapy for esophageal cancer. J Surg Oncol 2005;92:257-261.
6. Nobuto H, Sugita T, Kubo T, Shimose S, Yasunaga Y, Murakami T, Ochi M. Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet. Int J Cancer 2004;109:627-635.
7. Kim GJ, Nie S. Targeted cancer nanotherapy. Mater Today 2005;8:28-33.
8. Reisen JV, Polley GT, Verheijen PJ. Structural targeting for heat integration retrofit. Appl Therm Eng 1998;18:283-294.
9. Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999;15:345-370.
10. Chilkori A, Dreher MR, Meyer DE, Raucher D. Targeted drug delivery by thermally responsive polymers. Adv Drug Deliv Rev 2002;54:613-630.
11. Dewhirst MW, Prosnitz L, Thrall D, Prescott D, Clegg S, Charles C, MacFall J, Rosner G, Samulski T, Gillette E, LaReu S. Hyperthermic treatment of malignant diseases: Current status and a view toward the future. Semin Oncol 1997;24:616-625
12. Riehemann K, Schmitt O, Ehlers EM. The effects of thermochemotherapy using cyclophosphamide plus hyperthermia on the malignant pleural mesothelioma in vivo. Ann Anat 2005;187: 215-223.
13. Kohori F, Sakai K, Aoyagi T, Yokoyama M, Sakurai Y, Okano T. Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide). J Control Release 1998;55:87-98.
14. Schild HG. Poly(N-isopropylacrylamide): Experiment, theory and application. Prog Polym Sci 1992;17:163-249.
15. Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002;54:37-51.
16. Zhang JX, Qiu LY, Jin Y, Zhu KJ. Thermally responsive polymeric micelles self-assembled by amphophilic polyphosphazene with poly(N- isopropylacrylamide) and ethyl glycinate as side groups: Polymer synthesis, characterization, and in vitro drug release study. J Biomed Mater Res A 2006;76:773-780.
17. Chung JE, Yokoyama M, Yamato M, Aoyagi T, Sakurai Y, Okano T. Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). J Control Release 1999;62:115-127.
18. Meyer DE, Shin BC, Kong GA, Dewhirst MW, Chilkoti A. Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release 2001;74:213-224.
19. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: Design, Characterization and biological significance. Adv Drug Deliv Rev 2001;47:113-131.
20. Bostman O, Pihlajamaki H. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: A review. Biomaterials 2000;21:2615-2621.
21. Kosmas C, Tsavaris N, Mylonakis N, Kalofonos HP. An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer. Crit Rev Oncol Hematol 2003;45:265-275.
22. Belani CP, Eckardt J. Development of docetaxel in advanced non-small-cell lung cancer. Lung Cancer 2004;46:S3-S11.
23. Berry WR. The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer. Urology 2005; 65:2-7.
24. Fonseca C, Simoes S, Gaspar RE. Paclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release 2002;83: 273-286.
25. Yeh YA, Herenyiova M, Weber G. Quercetin: Synergistic action with carboxyamidotriazole in human breast carcinoma cells. Life Sci 1995;57:1285-1292.
26. Jang SH, Wientjes MG, Lu D, Au JLS. Drug delivery and transport to solid tumors. Pharm Res 2003;20:1337-1350.
27. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998;95:4607-4612.
28. Drummond DC, Meyer O, Hong KL, Kirpotin DB, Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 1999;51:691-743.
29. Zhang LY, Hu Y, Jiang XQ, Yang CZ, Lu W, Yang YH. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b- poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Release 2004;96:135-148.
30. Savie R, Luo L, Eisengerg A, Mayslinger D. Micellar nanocontainers distribute to difined cytoplasmic organelles. Science 2003; 300:615-618.
31. Shuai X, Merdan T, Schaper AK, Xi F, Kissel T. Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconjug Chem 2004;15:441-448.
32. Rapoport N. Combined cancer therapy by micellar-encapsulated drug and ultrasound. Int J Pharm 2004;277:155-162.